MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $44,125 | -88.1% | 3,041 | -77.4% | 0.00% | -100.0% |
| Q4 2021 | $371,000 | -60.9% | 13,450 | -54.2% | 0.00% | -66.7% |
| Q3 2021 | $949,000 | +343.5% | 29,383 | +319.8% | 0.00% | +200.0% |
| Q2 2021 | $214,000 | +0.5% | 7,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $213,000 | -54.8% | 7,000 | -31.6% | 0.00% | -66.7% |
| Q3 2018 | $471,000 | +106.6% | 10,230 | +67.5% | 0.00% | +200.0% |
| Q2 2018 | $228,000 | -89.7% | 6,107 | -94.2% | 0.00% | -94.7% |
| Q4 2013 | $2,210,000 | +140.0% | 105,321 | +168.8% | 0.02% | +90.0% |
| Q3 2013 | $921,000 | +39.8% | 39,177 | +59.8% | 0.01% | +11.1% |
| Q2 2013 | $659,000 | – | 24,522 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |